استعرض مصدر Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan



Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan
Shu-Yu Tai, Chen-Yu Chien, Deng-Chyang Wu, Kun-Der Lin, Bo-Lin Ho, Yu-Han Chang, Yang-Pei Chang 
Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan
Shu-Yu Tai,  Chen-Yu Chien,  Deng-Chyang Wu,  Kun-Der Lin,  Bo-Lin Ho,  Yu-Han Chang,  Yang-Pei Chang PLOS x
Published: February 15, 2017https://doi.org/10.1371/journal.pone.0171006
Article
Authors
Metrics
Comments
Related Content
Abstract
Introduction
Methods
Results
Discussion
Conclusions
Supporting information
Acknowledgments
Author Contributions
References
Reader Comments (0)
Media Coverage (0)
Figures
Abstract
Introduction
Concerns have been raised regarding the potential association between proton pump inhibitor (PPI) use and dementia.

Objective
This study aimed to examine this association in an Asian population.

Methods
Patients initiating PPI therapy between January 1, 2000 and December 31, 2003 without a prior history of dementia were identified from Taiwan’s National Health Insurance Research Database. The outcome of interest was all-cause dementia. Cox regression models were applied to estimate the hazard ratio (HR) of dementia. The cumulative PPI dosage stratified by quartiles of defined daily doses and adjusted for baseline disease risk score served as the primary variables compared against no PPI use.

Results
We analyzed the data of 15726 participants aged 40 years or older and free of dementia at baseline. PPI users (n = 7863; average follow-up 8.44 years) had a significantly increased risk of dementia over non—PPI users (n = 7863; average follow-up 9.55 years) (adjusted HR [aHR] 1.22; 95% confidence interval: 1.05–1.42). A significant association was observed between cumulative PPI use and risk of dementia (P for trend = .013). Subgroup analysis showed excess frequency of dementia in PPI users diagnosed with depression (aHR 2.73 [1.91–3.89]), hyperlipidemia (aHR 1.81 [1.38–2.38]), ischemic heart disease (aHR 1.55 [1.12–2.14]), and hypertension (aHR 1.54 [1.21–1.95]).

Conclusions
An increased risk for dementia was identified among the Asian PPI users. Cumulative PPI use was significantly associated with dementia. Further investigation into the possible biological mechanisms underlying the relationship between dementia and PPI use is warranted.

==مراجع==
{{مراجع}}


[[تصنيف:دمنشيا]]
[[تصنيف:رعاية المسنين في تايوان]]
[[تصنيف:Proton pump inhibitors]]